Search for: "Sanofi" Results 161 - 180 of 1,187
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
7 May 2020, 5:29 am by Annsley Merelle Ward
The AusKat won't be restrained fromlaunching to attack that wrinkle on thesheets.....In a long-awaited judgment that will affect applications in Australia for interlocutory injunctions to restrain launch of pharmaceutical products, as well as claims for compensation following wrongful exclusion of generic or biosimilar pharmaceuticals from the market, the Federal Court of Australia dismissed a claim made by the Commonwealth government for compensation from Sanofi (Commonwealth of… [read post]
23 May 2023, 2:37 pm by Holman
Sanofi, including Dennis’s prompt response. [read post]
2 Sep 2020, 4:50 pm by Howard Bashman
Sanofi, BMS must face revived whistleblower suit over Plavix marketing”: Brendan Pierson of Reuters has this report (subscription required for full access) on a ruling that the U.S. [read post]
7 Oct 2009, 9:59 pm
District Court for the District of New Jersey has signed off on Sanofi-Aventis' settlement agreement with Sun Pharmaceutical Industries Ltd. despite the fact that Sanofi failed to exchange all relevant signature pages. [read post]
8 Jul 2010, 9:59 pm by Patent Docs
Sanofi and Abbott responded by filing the current lawsuit in December 2007, alleging infringement of U.S. [read post]
26 Aug 2019, 4:15 am by IPWatchdog
Pfizer saw a lot of success last week in having seven IPRs instituted against Sanofi-Aventis, challenging four injectable insulin treatment patents that are at the center... [read post]
21 Mar 2023, 8:17 pm by Patent Docs
Sanofi is the first time in almost a hundred years that the Court has deigned to consider sufficiency of disclosure decisions, in this case enablement under 35 U.S.C. [read post]
19 Mar 2023, 9:32 pm by Patent Docs
Sanofi is the first time in almost a hundred years that the Court has deigned to consider sufficiency of disclosure decisions, in this case enablement under 35 U.S.C. [read post]
26 Oct 2018, 6:37 pm by Patent Docs
Sanofi: U.S. and European Perspectives -- Meeting Written Description and Obviousness Requirements" on November 7, 2018 from 1:00 to 2:30 pm (EST). [read post]
27 Mar 2011, 6:28 pm
Despite knowing that there was a severe risk of stroke, sanofi minimized the risk to Mr. [read post]
12 Dec 2008, 7:44 pm
The courts sided with Sanofi. [read post]